|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 14.14 USD | +2.09% |
|
+4.51% | -12.61% |
| Apr. 18 | NeoGenomics, Inc. Announces Senior Leadership Promotions | CI |
| Apr. 18 | NeoGenomics, Inc. Announces Eliminates of Position of Vishal Sikri, President, Advanced Diagnostics | CI |
NeoGenomics, Inc. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported revenue was USD 591.64 million compared to USD 509.73 million a year ago. Net loss was USD 87.97 million compared to USD 144.25 million a year ago.
Basic loss per share from continuing operations was USD 0.7 compared to USD 1.16 a year ago. Diluted loss per share from continuing operations was USD 0.7 compared to USD 1.16 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -12.61% | 1.81B | |
| -17.89% | 8.25B | |
| +39.20% | 3.58B | |
| -39.11% | 2.46B | |
| -8.06% | 2.46B | |
| -7.35% | 2.38B | |
| -19.01% | 1.55B | |
| -40.66% | 1.21B | |
| +7.56% | 1.11B | |
| -15.34% | 1.03B |
NEOGENOMICS, INC. 
